Exicure (XCUR) Amortizatization of Intangibles (2019 - 2026)
Exicure (XCUR) reported Amortizatization of Intangibles of $57000.0 for Q1 2026, up 21.28% on a YoY basis from $47000.0 in Q1 2025, and down 55.81% quarter-over-quarter from $129000.0 in Q4 2025.
Exicure (XCUR) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Exicure has reported Amortizatization of Intangibles for 8 years, with the latest figure at $57000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles rose 21.28% year-over-year to $57000.0; the trailing twelve-month figure through Mar 2026 stood at $228000.0 (down 64.87% YoY), and the FY2025 full-year result was $218000.0, down 72.61% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $57000.0, down from $129000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $691000.0 in Q4 2022, with the low at -$339000.0 in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $147352.9 across 5 years, with a median of $180000.0 in 2023.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles soared 69200.0% — and 2025, when it sank 107.46%.
- Exicure's Amortizatization of Intangibles stood at $691000.0 in 2022, then plunged by 72.5% to $190000.0 in 2023, then increased by 7.89% to $205000.0 in 2024, then sank by 37.07% to $129000.0 in 2025, then slumped by 55.81% to $57000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $57000.0 (Q1 2026), $129000.0 (Q4 2025), and -$15000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Exicure | 17.53 Mn | 14.92 Mn | - | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,000.00 |
| Mar 31, 2026 | 57,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Dec 31, 2025 | 129,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Sep 30, 2025 | -15,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Sep 30, 2024 | 201,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |
| Dec 31, 2023 | 190,000.00 |
| Dec 31, 2023 | 190,000.00 |